| scholarly article | Q13442814 |
| P50 | author | Johann Steiner | Q42319648 |
| Paul C Guest | Q56613790 | ||
| P2093 | author name string | Bernhard Bogerts | |
| Hans-Gert Bernstein | |||
| Henrik Dobrowolny | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 4-18 | |
| P577 | publication date | 2014-06-16 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy | |
| P478 | volume | 161 |
| Q26770756 | A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q48413495 | A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes |
| Q26773159 | Advancements in the Underlying Pathogenesis of Schizophrenia: Implications of DNA Methylation in Glial Cells |
| Q89964060 | Alterations of Astrocytes in the Context of Schizophrenic Dementia |
| Q38365916 | Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications |
| Q47680320 | Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis |
| Q36118835 | Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders |
| Q33619607 | Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories |
| Q91025656 | Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin |
| Q38281865 | Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. |
| Q35683865 | Brain in flames - animal models of psychosis: utility and limitations |
| Q64968607 | CYFIP1 overexpression increases fear response in mice but does not affect social or repetitive behavioral phenotypes. |
| Q47824709 | Cannabinoids and glial cells: possible mechanism to understand schizophrenia. |
| Q95320733 | Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study |
| Q48331812 | Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures |
| Q41465233 | Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination |
| Q39488903 | Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. |
| Q54995117 | Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia. |
| Q48022410 | DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disorders |
| Q101237248 | Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis |
| Q42314257 | Derivation of Functional Human Astrocytes from Cerebral Organoids. |
| Q89736173 | Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond |
| Q34531769 | Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules |
| Q50419804 | Dysregulation of miRNA and its potential therapeutic application in schizophrenia. |
| Q93164464 | Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype? |
| Q36579965 | Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction |
| Q38672722 | Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia |
| Q61798766 | Encephalitis, Mild Encephalitis, Neuroprogression, or Encephalopathy—Not Merely a Question of Terminology |
| Q40107932 | First description of enhanced expression of glia maturation factor-beta in experimantal toxoplasmic encephalitis |
| Q28067617 | From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism |
| Q48163616 | Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells |
| Q38373219 | Glia-related genes and their contribution to schizophrenia |
| Q91194418 | Glial cells in schizophrenia: a unified hypothesis |
| Q89313492 | Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test |
| Q39415063 | In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis |
| Q36915357 | In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma |
| Q52150395 | Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. |
| Q95500589 | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
| Q88687361 | Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability |
| Q91669841 | Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study |
| Q35598966 | MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia |
| Q47152736 | Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review |
| Q37199033 | Modeling psychiatric disorders: from genomic findings to cellular phenotypes |
| Q39408715 | Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs). |
| Q30383611 | Molecular substrates of schizophrenia: homeostatic signaling to connectivity |
| Q28074736 | Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs |
| Q47650825 | Myths and truths about the cellular composition of the human brain: A review of influential concepts |
| Q38728328 | Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors |
| Q41573540 | New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis |
| Q38926246 | New drug developments in psychosis: Challenges, opportunities and strategies |
| Q95270886 | Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia |
| Q30410688 | Potential primary roles of glial cells in the mechanisms of psychiatric disorders |
| Q90461595 | Progress in iPSC-Based Modeling of Psychiatric Disorders |
| Q35933481 | Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder |
| Q26750910 | Role of astrocytic glutamate transporter in alcohol use disorder |
| Q36615271 | Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis. |
| Q36175299 | Sonic hedgehog functions upstream of disrupted-in-schizophrenia 1 (disc1): implications for mental illness |
| Q92378165 | Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models |
| Q59330239 | Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems |
| Q36246819 | Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia |
| Q99711312 | The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders |
| Q41286620 | The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence |
| Q47875785 | The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening |
| Q91971337 | The Principles of Electroconvulsive Therapy Based on Correlations of Schizophrenia and Epilepsy: A View From Brain Networks |
| Q42517262 | The ketone body metabolite β-hydroxybutyrate induces an antidepression-associated ramification of microglia via HDACs inhibition-triggered Akt-small RhoGTPase activation. |
| Q88129356 | The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients |
| Q38836341 | The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting |
| Q52367971 | The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia. |
| Q40369760 | Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia |
| Q98158696 | Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia |
| Q38716873 | Understanding the genetic liability to schizophrenia through the neuroepigenome |
Search more.